Not Medicare Enrolled

Dr. John Naus, MD

Psychiatry · Colleyville, TX
5017 HERITAGE AVE, Colleyville, TX 76034
8175459100
Registered in NPPES since 2007
NPI: 1932328291 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Naus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naus? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Naus

Dr. John Naus is a psychiatry specialist in Colleyville, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Naus received a total of $187,565 from 42 pharmaceutical and/or device companies across 913 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Naus is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $187,565 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$187,565
Total received (2018-2024)
Avg $26,795/year across 7 years
Top 2% in TX for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
913
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$23,149
2023
$28,402
2022
$19,599
2021
$20,964
2020
$2,756
2019
$28,185
2018
$64,511

Payments by company (2024)

Supernus Pharmaceuticals, Inc.
$11,909
Teva Pharmaceuticals USA, Inc.
$6,257
E.R. Squibb & Sons, L.L.C.
$2,386
Otsuka America Pharmaceutical, Inc.
$1,218
Axsome Therapeutics, Inc.
$251
Neurocrine Biosciences, Inc.
$212
Corium, LLC
$173
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$145
Takeda Pharmaceuticals U.S.A., Inc.
$91
Tris Pharma Inc
$86
Lundbeck LLC
$83
ABBVIE INC.
$69
Validus Pharmaceuticals LLC
$61
Alkermes, Inc.
$51
Janssen Pharmaceuticals, Inc
$35
Avadel CNS Pharmaceuticals, LLC
$32
IDORSIA PHARMACEUTICALS US INC
$23
JAZZ PHARMACEUTICALS INC.
$21
IRONSHORE PHARMACEUTICALS INC.
$17
Neos Therapeutics, LP
$14
Noven Therapeutics, LLC
$13
Top 3 companies account for 88.8% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$56,713
Sunovion Pharmaceuticals Inc.
$42,361
Supernus Pharmaceuticals, Inc.
$29,883
Teva Pharmaceuticals USA, Inc.
$24,025
Takeda Pharmaceuticals U.S.A., Inc.
$11,719
Neos Therapeutics, LP
$9,869
Allergan Inc.
$3,100
E.R. Squibb & Sons, L.L.C.
$2,386
ITI, Inc.
$1,542
Validus Pharmaceuticals LLC
$749
Neurocrine Biosciences, Inc.
$691
Lundbeck LLC
$602
Axsome Therapeutics, Inc.
$448
Corium, LLC
$441
Otsuka Pharmaceutical Development & Commercialization, Inc.
$389
Vanda Pharmaceuticals Inc.
$382
Janssen Pharmaceuticals, Inc
$229
Alkermes, Inc.
$222
Shire North American Group Inc
$221
Tris Pharma Inc
$162
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$145
ABBVIE INC.
$132
JAZZ PHARMACEUTICALS INC.
$130
ARBOR PHARMACEUTICALS, INC.
$127
Ironshore Pharmaceuticals Inc.
$123
Avanir Pharmaceuticals, Inc.
$119
Vertical Pharmaceuticals, LLC
$92
Noven Therapeutics, LLC
$83
Jazz Pharmaceuticals Inc.
$83
Allergan, Inc.
$68
IDORSIA PHARMACEUTICALS US INC
$59
Bausch Health US, LLC
$39
Masimo Corporation
$36
Avadel CNS Pharmaceuticals, LLC
$32
Merck Sharp & Dohme LLC
$31
Almatica Pharma LLC
$29
Adlon Therapeutics L.P.
$28
Harmony Biosciences LLC
$18
IRONSHORE PHARMACEUTICALS INC.
$17
AbbVie Inc.
$17
EISAI INC.
$12
OWP Pharmaceuticals, Inc.
$11
Top 3 companies account for 68.8% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · DIVIGEL · Dayvigo · Dyanavel XR · Equetro · Evekeo · Fanapt · HETLIOZ · Hetlioz · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LUMRYZ · LYBALVI · Lamotrigine Starter Kit · METHYLPHENIDATE 72 · MYDAYIS · NUEDEXTA · QELBREE · QUVIVIQ · Qelbree · RELEXXII · REXULTI · SECUADO · SERTRALINE HCL · SPRAVATO · SUNOSI · Sunosi · TRINTELLIX · Trintellix · UZEDY · VIIBRYD · VRAYLAR · VYVANSE · Wakix · XIIDRA · XYREM · XYWAV · Xelstrym · Xyrem
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Colleyville?
Compare psychiatrists in the Colleyville area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
608
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
SAINT CAMILLUS MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Naus is a psychiatry specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Naus receive payments from pharmaceutical companies?
Yes. Dr. Naus received a total of $187,565 from 42 companies across 913 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Naus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in Colleyville
Browse psychiatrists in Colleyville ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in TX
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in TX
Which TX psychiatrists receive the most from drug and device companies.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →